Anders Behndig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anders Behndig has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Björn Lundberg
Department of Clinical Sciences/Ophtalmology, Umeå University, Umeå, Sweden
4 shared publicationsEva Mönestam
2 shared publicationsLaurent Kodjikian
2 shared publicationsMaria Kugelberg
Karolinska Institutet St. Erik Eye Hospital Stockholm Sweden
2 shared publications- Marie-José Tassignon
Department of Ophthalmology, Antwerp University Hospital, Edegem, and Brussels University Hospital VUB, Belgium
2 shared publications Mats Lundström
Department of Clinical Sciences, Ophthalmology Faculty of Medicine Lund University Lund Sweden
2 shared publications
Latest Publications
- Open Access
- 29 November 2016
- Published by Springer Nature in BMC Ophthalmology
- Vol. 16 (1) , 210
Oestradiol levels and superoxide dismutase activity in age-related cataract: a case–control study
It has been suggested that the higher prevalence of cataract in women is caused by a withdrawal effect of oestrogen at menopause. In vitro studies have demonstrated protection of serum oestradiol (E2) against oxidative stress through upregulation of antioxidant enzymes, including superoxide dismutase (SOD). The purpose of the present study was to investigate E2 levels and SOD erythrocyte activity in patients with age-related cataract. The studied subjects consisted of 103 patients with age-related cataract and 22 controls. Cataracts were classified as nuclear, cortical, or posterior subcapsular. Blood samples were collected and data on smoking, hormonal use, diabetes and age at menarche/menopause was obtained for all individuals. Serum oestradiol analyses were performed with radioimmunoassay (RIA) and SOD activity was measured in erythrocyte lysates. A negative correlation between age and E2 concentration was seen in a linear regression analysis. No correlation was seen between SOD activity and age or gender and no correlation between E2 levels and SOD activity was found using multiple linear regression. The mean level of E2 for all male subjects was 50.1 ± 16.3 pmol/L, significantly higher compared to 13.8 ± 11.8 pmol/L for postmenopausal women. The present study does not support a role for E2-induced effects on SOD in cataract formation. The findings of higher E2 levels in men than in postmenopausal women may suggest that decreased oestrogen at menopause is partially responsible for the gender-related difference in cataract prevalence. However, the latter can only be verified through prospective randomized trials using hormonal replacement therapy.
- 29 November 2016
- Published by Springer Nature in BMC Ophthalmology
- Vol. 16 (1) , 210
Open AccessOestradiol levels and superoxide dismutase activity in age-related cataract: a case–control study
It has been suggested that the higher prevalence of cataract in women is caused by a withdrawal effect of oestrogen at menopause. In vitro studies have demonstrated protection of serum oestradiol (E2) against oxidative stress through upregulation of antioxidant enzymes, including superoxide dismutase (SOD). The purpose of the present study was to investigate E2 levels and SOD erythrocyte activity in patients with age-related cataract. The studied subjects consisted of 103 patients with age-related cataract and 22 controls. Cataracts were classified as nuclear, cortical, or posterior subcapsular. Blood samples were collected and data on smoking, hormonal use, diabetes and age at menarche/menopause was obtained for all individuals. Serum oestradiol analyses were performed with radioimmunoassay (RIA) and SOD activity was measured in erythrocyte lysates. A negative correlation between age and E2 concentration was seen in a linear regression analysis. No correlation was seen between SOD activity and age or gender and no correlation between E2 levels and SOD activity was found using multiple linear regression. The mean level of E2 for all male subjects was 50.1 ± 16.3 pmol/L, significantly higher compared to 13.8 ± 11.8 pmol/L for postmenopausal women. The present study does not support a role for E2-induced effects on SOD in cataract formation. The findings of higher E2 levels in men than in postmenopausal women may suggest that decreased oestrogen at menopause is partially responsible for the gender-related difference in cataract prevalence. However, the latter can only be verified through prospective randomized trials using hormonal replacement therapy.
- Open Access
- 1 December 2015
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 41 (12) , 2635-2643
Surgical, antiseptic, and antibiotic practice in cataract surgery: Results from the European Observatory in 2013
To report the results from the first iteration of the European Observatory of Cataract Surgery, which was initiated to track changes in surgical, antiseptic, and antibiotic practices in cataract surgery over the coming years. Practicing European cataract surgeons (n = 479). Internet-based declarative questionnaire or telephone questionnaire. The questionnaire comprised 37 questions divided into 8 categories as follows: screening, surgeon profile, surgical procedure used, product use before arrival at the operating room, techniques for mydriasis and anesthesia, product use during the surgery, product use after the patient leaves the operating room, and surgeon's attitude to guidelines. Cataract surgeons (n = 2700) were initially contacted, of whom 479 (17.7%) were included in the survey. The current baseline survey revealed considerable variation between countries in their implementation of infectious postoperative endophthalmitis (IPOE) prophylaxis. In some countries, adoption of intracameral cefuroxime is almost universal, whereas in others, the use of such prophylaxis is below one half. When intracameral cefuroxime is used, it is generally cefuroxime powder designed for parenteral use. A preparation specifically registered for intracameral use is now available, and this formulation is more commonly used in countries in which intracameral cefuroxime was most widely adopted. The baseline results from this ongoing survey suggest a considerable level of heterogeneity between European countries in IPOE prophylaxis. Further iterations of this survey will monitor whether a consensus begins to emerge. This work was supported by Laboratoires Théa, under the supervision of the expert group. Members of the expert group were remunerated by Laboratoires Théa. J.F. Stolz, MD, PhD, provided editorial assistance in manuscript preparation, for which he was remunerated by Laboratoires Théa. Anders Behndig, Rita Mencucci, and Jacek P. Szaflik report no relevant conflicts of interest.
- 1 December 2015
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 41 (12) , 2635-2643
Open AccessSurgical, antiseptic, and antibiotic practice in cataract surgery: Results from the European Observatory in 2013
To report the results from the first iteration of the European Observatory of Cataract Surgery, which was initiated to track changes in surgical, antiseptic, and antibiotic practices in cataract surgery over the coming years. Practicing European cataract surgeons (n = 479). Internet-based declarative questionnaire or telephone questionnaire. The questionnaire comprised 37 questions divided into 8 categories as follows: screening, surgeon profile, surgical procedure used, product use before arrival at the operating room, techniques for mydriasis and anesthesia, product use during the surgery, product use after the patient leaves the operating room, and surgeon's attitude to guidelines. Cataract surgeons (n = 2700) were initially contacted, of whom 479 (17.7%) were included in the survey. The current baseline survey revealed considerable variation between countries in their implementation of infectious postoperative endophthalmitis (IPOE) prophylaxis. In some countries, adoption of intracameral cefuroxime is almost universal, whereas in others, the use of such prophylaxis is below one half. When intracameral cefuroxime is used, it is generally cefuroxime powder designed for parenteral use. A preparation specifically registered for intracameral use is now available, and this formulation is more commonly used in countries in which intracameral cefuroxime was most widely adopted. The baseline results from this ongoing survey suggest a considerable level of heterogeneity between European countries in IPOE prophylaxis. Further iterations of this survey will monitor whether a consensus begins to emerge. This work was supported by Laboratoires Théa, under the supervision of the expert group. Members of the expert group were remunerated by Laboratoires Théa. J.F. Stolz, MD, PhD, provided editorial assistance in manuscript preparation, for which he was remunerated by Laboratoires Théa. Anders Behndig, Rita Mencucci, and Jacek P. Szaflik report no relevant conflicts of interest.
- 1 July 2015
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 41 (7) , 1503-1519
Mydriatic insert and intracameral injections compared with mydriatic eyedrops in cataract surgery: Controlled studies
Mydriatic eyedrops are the standard method for pupil dilation in cataract surgery, but their limitations have prompted a search for alternative techniques. Two alternatives-an ophthalmic insert containing phenylephrine and tropicamide and intracameral injections of various combinations of lidocaine, cyclopentolate, and phenylephrine, with or without epinephrine in the irrigating solution-have been assessed in prospective controlled studies, including randomized controlled trials (RCTs). We reviewed the safety and efficacy of mydriatic ophthalmic inserts and intracameral mydriatic injections compared with the safety and efficacy of mydriatic eyedrops using a systematic PubMed search (1963 to 2014). We identified 9 prospective studies (7 RCTs, 637 patients) of the mydriatic ophthalmic insert and 15 prospective studies (14 RCTs, 1020 patients) of intracameral mydriatic injections; 7 of the RCTs compared intracameral mydriatic injections and mydriatic eyedrops and 7 RCTs studied the optimum intracameral mydriatic injection protocol. The latter showed that a lidocaine and phenylephrine-based solution, without irrigating epinephrine, was optimum for intracameral mydriatic injections. The mydriatic ophthalmic insert and intracameral mydriatic injections were consistently shown to be safe and as effective as mydriatic eyedrops. Each method has distinct advantages and limitations. Dr. Behndig has received fees from Théa Pharma GmbH as a member of the European Team for the Prophylaxis of Infection in Cataract Surgery group. Dr. Korobelnik has received consultancy fees from Alcon Surgical, Inc.; Allergan, Inc.; Alimera, Inc.; Bayer HealthCare AG; Carl Zeiss Meditec AG; Novartis Corp.; Roche Innovatis AG; and Théa Pharma GmbH.
- 1 July 2015
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 41 (7) , 1503-1519
Mydriatic insert and intracameral injections compared with mydriatic eyedrops in cataract surgery: Controlled studies
Mydriatic eyedrops are the standard method for pupil dilation in cataract surgery, but their limitations have prompted a search for alternative techniques. Two alternatives-an ophthalmic insert containing phenylephrine and tropicamide and intracameral injections of various combinations of lidocaine, cyclopentolate, and phenylephrine, with or without epinephrine in the irrigating solution-have been assessed in prospective controlled studies, including randomized controlled trials (RCTs). We reviewed the safety and efficacy of mydriatic ophthalmic inserts and intracameral mydriatic injections compared with the safety and efficacy of mydriatic eyedrops using a systematic PubMed search (1963 to 2014). We identified 9 prospective studies (7 RCTs, 637 patients) of the mydriatic ophthalmic insert and 15 prospective studies (14 RCTs, 1020 patients) of intracameral mydriatic injections; 7 of the RCTs compared intracameral mydriatic injections and mydriatic eyedrops and 7 RCTs studied the optimum intracameral mydriatic injection protocol. The latter showed that a lidocaine and phenylephrine-based solution, without irrigating epinephrine, was optimum for intracameral mydriatic injections. The mydriatic ophthalmic insert and intracameral mydriatic injections were consistently shown to be safe and as effective as mydriatic eyedrops. Each method has distinct advantages and limitations. Dr. Behndig has received fees from Théa Pharma GmbH as a member of the European Team for the Prophylaxis of Infection in Cataract Surgery group. Dr. Korobelnik has received consultancy fees from Alcon Surgical, Inc.; Allergan, Inc.; Alimera, Inc.; Bayer HealthCare AG; Carl Zeiss Meditec AG; Novartis Corp.; Roche Innovatis AG; and Théa Pharma GmbH.
- 27 September 2014
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 25 (2) , 108-111
Gender Differences in Refractive Prediction in Refractive Lens Exchange Surgery
Purpose: To compare the refractive outcomes after refractive lens exchange (RLE) surgery with regards to gender and intraocular lens (IOL) power calculation formula. Methods: A cohort of consecutive patients operated with bilateral same-day RLE surgery at a private eye clinic (n = 512) was studied. Target refraction was emmetropia in all cases and Haigis formula was used for all IOL power calculations. One month after surgery, subjective refraction was assessed and the absolute refractive prediction error (RPEAbs), as well as the refractive prediction error with correct signs (RPESign), was calculated, as were the refractive outcomes with the SRK/T formula. Results: For the whole cohort, the Haigis formula rendered a significantly smaller RPEAbs than the SRK/T formula (0.16 ± 0.26 D vs 0.32 ± 0.30 D; pAbs was seen. A slight myopic error was seen with the SRK/T formula in women, and a slight hyperopic error in men (-0.06 ± 0.47 D vs + 0.16 ± 0.39 D; p<0.001). No similar gender difference was seen with the Haigis formula (+0.05 ± 0.29 D vs +0.05 ± 0.31 D; p = NS). Axial length, anterior chamber depth, and corneal steepness differed significantly between the sexes. Conclusions: The Haigis formula generally performed better in this RLE cohort. The SRK/T formula generates a small myopic error in women and a hyperopic error in men, associated with flatter corneas, longer axial lengths, and deeper anterior chambers in the latter.
- 27 September 2014
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 25 (2) , 108-111
Gender Differences in Refractive Prediction in Refractive Lens Exchange Surgery
Purpose: To compare the refractive outcomes after refractive lens exchange (RLE) surgery with regards to gender and intraocular lens (IOL) power calculation formula. Methods: A cohort of consecutive patients operated with bilateral same-day RLE surgery at a private eye clinic (n = 512) was studied. Target refraction was emmetropia in all cases and Haigis formula was used for all IOL power calculations. One month after surgery, subjective refraction was assessed and the absolute refractive prediction error (RPEAbs), as well as the refractive prediction error with correct signs (RPESign), was calculated, as were the refractive outcomes with the SRK/T formula. Results: For the whole cohort, the Haigis formula rendered a significantly smaller RPEAbs than the SRK/T formula (0.16 ± 0.26 D vs 0.32 ± 0.30 D; pAbs was seen. A slight myopic error was seen with the SRK/T formula in women, and a slight hyperopic error in men (-0.06 ± 0.47 D vs + 0.16 ± 0.39 D; p<0.001). No similar gender difference was seen with the Haigis formula (+0.05 ± 0.29 D vs +0.05 ± 0.31 D; p = NS). Axial length, anterior chamber depth, and corneal steepness differed significantly between the sexes. Conclusions: The Haigis formula generally performed better in this RLE cohort. The SRK/T formula generates a small myopic error in women and a hyperopic error in men, associated with flatter corneas, longer axial lengths, and deeper anterior chambers in the latter.
- 15 June 2014
- Published by Wiley in Acta Ophthalmologica
- Vol. 92 (8) , 759-763
Gender differences in biometry prediction error and intra‐ocular lens power calculation formula
Purpose: To analyze changes over time in biometry prediction error (BPE) after cataract surgery with special reference to the impact of gender and the intra‐ocular lens (IOL) calculation formula.Methods: About 65% of Swedish cataract surgery units participating in the outcome registration of the National Cataract Register (NCR) were included in this prospective register study. Data for planned and postoperative refraction and keratometry during the month of March 2004–2013 were analyzed, divided by gender. The newly introduced variables axial length and IOL calculation formula were analyzed for March 2013. Gender differences in BPE with correct sign (BPESign) and absolute biometry prediction error (BPEAbs) were compared for the Haigis' and Sanders‐Retzlaff‐Kraff T (SRK/T) formulas.Results: The BPEAbs decreased throughout the study period. In 2004–2006, the BPEAbs was larger in women than in men (p < 0.05), but this difference disappeared from 2007. For 2004 through 2009, the mean BPESign was −0.105 ± 0.79D for women, but −0.003 ± 0.73D for men. After 2009, this myopic error for women gradually diminished. The Haigis' formula performed better in women than the SRK/T formula (p < 0.001); the SRK/T formula rendered a BPESign similar to that from 2004 to 2009 in women. Women had steeper corneas and shorter axial lengths than men (p < 0.001).Conclusion: The myopic BPE in women – associated with steeper corneas and shorter axial lengths – is decreasing, possibly owing to an increased use of the Haigis' formula. Using the Haigis' formula to a higher extent can potentially further reduce the BPEs after cataract surgery.
- 15 June 2014
- Published by Wiley in Acta Ophthalmologica
- Vol. 92 (8) , 759-763
Gender differences in biometry prediction error and intra‐ocular lens power calculation formula
Purpose: To analyze changes over time in biometry prediction error (BPE) after cataract surgery with special reference to the impact of gender and the intra‐ocular lens (IOL) calculation formula.Methods: About 65% of Swedish cataract surgery units participating in the outcome registration of the National Cataract Register (NCR) were included in this prospective register study. Data for planned and postoperative refraction and keratometry during the month of March 2004–2013 were analyzed, divided by gender. The newly introduced variables axial length and IOL calculation formula were analyzed for March 2013. Gender differences in BPE with correct sign (BPESign) and absolute biometry prediction error (BPEAbs) were compared for the Haigis' and Sanders‐Retzlaff‐Kraff T (SRK/T) formulas.Results: The BPEAbs decreased throughout the study period. In 2004–2006, the BPEAbs was larger in women than in men (p < 0.05), but this difference disappeared from 2007. For 2004 through 2009, the mean BPESign was −0.105 ± 0.79D for women, but −0.003 ± 0.73D for men. After 2009, this myopic error for women gradually diminished. The Haigis' formula performed better in women than the SRK/T formula (p < 0.001); the SRK/T formula rendered a BPESign similar to that from 2004 to 2009 in women. Women had steeper corneas and shorter axial lengths than men (p < 0.001).Conclusion: The myopic BPE in women – associated with steeper corneas and shorter axial lengths – is decreasing, possibly owing to an increased use of the Haigis' formula. Using the Haigis' formula to a higher extent can potentially further reduce the BPEs after cataract surgery.
- Open Access
- 1 September 2013
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 39 (9) , 1421-1431
Endophthalmitis prophylaxis in cataract surgery: Overview of current practice patterns in 9 European countries
Data on practice patterns for prophylaxis against infectious postoperative endophthalmitis (IPOE) during cataract surgery in 9 European countries were searched in national registers and reviews of published surveys. Summary reports assessed each nation's IPOE rates, nonantibiotic prophylactic routines, topical and intracameral antibiotic use, and coherence to the European Society of Cataract & Refractive Surgeons (ESCRS) 2007 guidelines. Although the reliability and completeness of available data vary between countries, the results show that IPOE rates differ significantly. Asepsis routines with povidone-iodine and postoperative topical antibiotics are generally adopted. Use of preoperative and perioperative topical antibiotics as well as intracameral cefuroxime varies widely between and within countries. Five years after publication of the ESCRS guidelines, there is no consensus on intracameral cefuroxime use. Major obstacles include legal barriers or persisting controversy about the scientific rationale for systematic intracameral cefuroxime use in some countries and, until recently, lack of a commercially available preparation.
- 1 September 2013
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 39 (9) , 1421-1431
Open AccessEndophthalmitis prophylaxis in cataract surgery: Overview of current practice patterns in 9 European countries
Data on practice patterns for prophylaxis against infectious postoperative endophthalmitis (IPOE) during cataract surgery in 9 European countries were searched in national registers and reviews of published surveys. Summary reports assessed each nation's IPOE rates, nonantibiotic prophylactic routines, topical and intracameral antibiotic use, and coherence to the European Society of Cataract & Refractive Surgeons (ESCRS) 2007 guidelines. Although the reliability and completeness of available data vary between countries, the results show that IPOE rates differ significantly. Asepsis routines with povidone-iodine and postoperative topical antibiotics are generally adopted. Use of preoperative and perioperative topical antibiotics as well as intracameral cefuroxime varies widely between and within countries. Five years after publication of the ESCRS guidelines, there is no consensus on intracameral cefuroxime use. Major obstacles include legal barriers or persisting controversy about the scientific rationale for systematic intracameral cefuroxime use in some countries and, until recently, lack of a commercially available preparation.
- 27 August 2013
- Published by Wiley in Acta Ophthalmologica
- Vol. 92 (5) , 482-485
A paired comparison of intracameral mydriatics in refractive lens exchange surgery
To compare the efficacy and intra-operative safety of intracameral mydriatics to topical mydriatics in patients undergoing refractive lens exchange (RLE) surgery. In a randomized intra-individually comparing study performed at Koskelas Eye Clinic, Luleå, and Department of Clinical Sciences/Ophthalmology, Umeå University Hospital, Umeå, Sweden, 56 patients undergoing same-day bilateral RLE were included. Pupils were randomly dilated with topical mydriatics in one eye and intracameral mydriatics in the fellow eye. Pupil sizes were recorded intra-operatively throughout the procedures. Perceived pain/discomfort and glare were assessed immediately postoperatively using a visual analogue scale from 0 to 10. Topical mydriatics and intracameral mydriatics both give satisfactory pupil dilation in routine RLE. However, there was noticeable iris billowing in 17 eyes dilated with topical mydriatics but only one eye with intracameral mydriatics (p < 0.001). Pupils were initially slightly larger in the topical mydriatics group but contracted during surgery. There was no perceived difference with regards to glare, pain or discomfort between the treatments. The surgeon graded intracameral mydriatics eyes as easier to operate on. Both topical mydriatics and intracameral mydriatics give satisfactory mydriasis for RLE, but pupil constriction and iris billowing are more pronounced with topical mydriatics.
- 27 August 2013
- Published by Wiley in Acta Ophthalmologica
- Vol. 92 (5) , 482-485
A paired comparison of intracameral mydriatics in refractive lens exchange surgery
To compare the efficacy and intra-operative safety of intracameral mydriatics to topical mydriatics in patients undergoing refractive lens exchange (RLE) surgery. In a randomized intra-individually comparing study performed at Koskelas Eye Clinic, Luleå, and Department of Clinical Sciences/Ophthalmology, Umeå University Hospital, Umeå, Sweden, 56 patients undergoing same-day bilateral RLE were included. Pupils were randomly dilated with topical mydriatics in one eye and intracameral mydriatics in the fellow eye. Pupil sizes were recorded intra-operatively throughout the procedures. Perceived pain/discomfort and glare were assessed immediately postoperatively using a visual analogue scale from 0 to 10. Topical mydriatics and intracameral mydriatics both give satisfactory pupil dilation in routine RLE. However, there was noticeable iris billowing in 17 eyes dilated with topical mydriatics but only one eye with intracameral mydriatics (p < 0.001). Pupils were initially slightly larger in the topical mydriatics group but contracted during surgery. There was no perceived difference with regards to glare, pain or discomfort between the treatments. The surgeon graded intracameral mydriatics eyes as easier to operate on. Both topical mydriatics and intracameral mydriatics give satisfactory mydriasis for RLE, but pupil constriction and iris billowing are more pronounced with topical mydriatics.
- 11 September 2012
- Published by Wiley in Acta Ophthalmologica
- Vol. 91 (7) , 657-659
Posterior chamber injection of intracameral mydriatics increases the durability of the mydriatic response
To compare the mydriatic effect of intracameral mydriatics injected into the anterior or the posterior chamber in routine phacoemulsification cataract surgery. Forty-four patients planned for unilateral phacoemulsification surgery were included after informed consent. Mydriasis was achieved by injecting 150 μl of a mixture of phenylephrine 1.5% and lidocaine 1.0% at the beginning of the procedure. The patients were randomly assigned to injection into the anterior or the posterior chamber. The pupils were filmed during the procedures, and the mean pupil diameters were measured at predetermined intervals from the video recordings by an independent observer. Immediately after the injection, the pupils were larger after posterior chamber injection (3.8 ± 0.8 versus 3.1 ± 0.7 mm; p = 0.004). A similar difference was seen after the phacoemulsification (6.4 ± 0.7 versus 5.9 ± 1.0 mm; p = 0.031). The mydriatic durability was also better after posterior injection (p = 0.004-0.041). Apart from immediately after the injection, the initial mydriatic response was similar with both injection techniques, but the durability of the mydriasis was slightly better after a posterior chamber injection of ICM.
- 11 September 2012
- Published by Wiley in Acta Ophthalmologica
- Vol. 91 (7) , 657-659
Posterior chamber injection of intracameral mydriatics increases the durability of the mydriatic response
To compare the mydriatic effect of intracameral mydriatics injected into the anterior or the posterior chamber in routine phacoemulsification cataract surgery. Forty-four patients planned for unilateral phacoemulsification surgery were included after informed consent. Mydriasis was achieved by injecting 150 μl of a mixture of phenylephrine 1.5% and lidocaine 1.0% at the beginning of the procedure. The patients were randomly assigned to injection into the anterior or the posterior chamber. The pupils were filmed during the procedures, and the mean pupil diameters were measured at predetermined intervals from the video recordings by an independent observer. Immediately after the injection, the pupils were larger after posterior chamber injection (3.8 ± 0.8 versus 3.1 ± 0.7 mm; p = 0.004). A similar difference was seen after the phacoemulsification (6.4 ± 0.7 versus 5.9 ± 1.0 mm; p = 0.031). The mydriatic durability was also better after posterior injection (p = 0.004-0.041). Apart from immediately after the injection, the initial mydriatic response was similar with both injection techniques, but the durability of the mydriasis was slightly better after a posterior chamber injection of ICM.
- 1 August 2011
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 37 (8) , 1539-1545
One million cataract surgeries: Swedish National Cataract Register 1992–2009
This review summarizes data collected by the Swedish National Cataract Register, which now contains data pertaining to more than a million cataract surgery procedures, representing 95.6% of the surgeries performed in Sweden during 1992-2009. During this period, the rate of cataract surgery rose from 4.47 to 9.00 per 1000 inhabitants. The mean patient age increased until 1999 but has slowly decreased since then. Preoperative visual acuity has risen steadily. The distribution between the sexes was stable until 2000, after which the proportion of women slowly decreased. Registration of subjective benefit has brought new knowledge regarding indications and expectations. An improved questionnaire, Catquest-9SF has been used since 2008. The outcome register generally shows good results from the surgery. Endophthalmitis has decreased from 0.10% to below 0.040%.
- 1 August 2011
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 37 (8) , 1539-1545
One million cataract surgeries: Swedish National Cataract Register 1992–2009
This review summarizes data collected by the Swedish National Cataract Register, which now contains data pertaining to more than a million cataract surgery procedures, representing 95.6% of the surgeries performed in Sweden during 1992-2009. During this period, the rate of cataract surgery rose from 4.47 to 9.00 per 1000 inhabitants. The mean patient age increased until 1999 but has slowly decreased since then. Preoperative visual acuity has risen steadily. The distribution between the sexes was stable until 2000, after which the proportion of women slowly decreased. Registration of subjective benefit has brought new knowledge regarding indications and expectations. An improved questionnaire, Catquest-9SF has been used since 2008. The outcome register generally shows good results from the surgery. Endophthalmitis has decreased from 0.10% to below 0.040%.